I was referring to IV, and I am happy to report that no poster there supports Gliead discussion of M&A prospects. My reading of a rather long thread there is that the posters generally see no need for Gilead to be 'anxious' to do M&A. If we are looking at an already great biotech company, in terms of its world-wide contributions, management has no need to be concerned about 'pushing' the stock price with exciting news on the M&A front.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.